![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1498, 2005-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Early, high-dose thyroxine benefits neonates with CH?
Inpharma, Vol. 1, Iss. 1237, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
High-dose chemotherapy effective in advanced sarcoma?
Inpharma, Vol. 1, Iss. 1268, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
High-dose chemotherapy superior in germ cell tumours?
Inpharma, Vol. 1, Iss. 1221, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 561, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
IFN- cost effective for MS after all?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 272, 2000-01 ,pp. :